LeMaitre Vascular (STU:LHU) Shares Outstanding (EOP): 22.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:LHU LeMaitre Vascular Inc STU:LHU
98 GF Score
Price €69.00
GF Value €81.33
Valuation Modestly Undervalued
View Full Analysis

What is LeMaitre Vascular Shares Outstanding (EOP)?

LeMaitre Vascular STU:LHU +0.73% 98 Shares Outstanding (EOP) is 22.8 Mil as of Jun. 2026. GuruFocus rates STU:LHU with a GF Score™ of 98/100 and a GF Value™ of €81.33 (Modestly Undervalued).

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. LeMaitre Vascular's shares outstanding for the quarter that ended in Jun. 2026 was 22.8 Mil.

LeMaitre Vascular's quarterly shares outstanding stayed the same from Mar. 2026 (22.8 Mil) to Jun. 2026 (22.8 Mil).

LeMaitre Vascular's annual shares outstanding increased from Dec. 2024 (22.5 Mil) to Dec. 2025 (22.8 Mil). It means LeMaitre Vascular issued new shares from Dec. 2024 to Dec. 2025 .


LeMaitre Vascular  (STU:LHU) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


LeMaitre Vascular Shares Outstanding (EOP) Related Terms


LeMaitre Vascular Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for LeMaitre Vascular's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeMaitre Vascular Shares Outstanding (EOP) Chart

LeMaitre Vascular Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.92 22.09 22.33 22.55 22.77

LeMaitre Vascular Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.64 22.68 22.77 22.85 22.85

STU:LHU vs PLSE, XRAY, ATRC: Shares Outstanding (EOP) Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Shares Outstanding (EOP) falls into.


STU:LHU
98GF Score
LeMaitre Vascular Inc STU:LHU
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeMaitre Vascular Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 22.8 Mil mean?
LeMaitre Vascular (STU:LHU) has a Shares Outstanding (EOP) of 22.8 Mil as of Jun. 2026. The total shares a company has outstanding, at period-end. View historical data on LeMaitre Vascular and its competitors.
Is LeMaitre Vascular's Shares Outstanding (EOP) too high?
LeMaitre Vascular's current Shares Outstanding (EOP) is 22.8 Mil. Overall, LeMaitre Vascular has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Shares Outstanding (EOP) compare to PLSE and XRAY?
LeMaitre Vascular's Shares Outstanding (EOP) of 22.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on LeMaitre Vascular and its competitors. LeMaitre Vascular's current Shares Outstanding (EOP) is 22.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (STU:LHU) is currently considered Modestly Undervalued. The stock's GF Value™ is €81.33, compared to a current price of €69.00 — trading 15.2% below its estimated fair value. The current Shares Outstanding (EOP) is 22.8 Mil. LeMaitre Vascular's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For LeMaitre Vascular (STU:LHU), the current Shares Outstanding (EOP) is 22.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LeMaitre Vascular (STU:LHU) Overvalued in 2026?

Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued. The current stock price of €69.00 is trading 15.2% below its estimated GF Value™ of €81.33. GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.

Key valuation signals for STU:LHU:

  • Shares Outstanding (EOP): 22.8 Mil
  • GF Value™: €81.33 vs. price of €69.00 (15.2% below fair value)
  • GF Score™: 98/100

No single metric tells the full story. See the STU:LHU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LeMaitre Vascular Business Description

Other Exchanges LMAT:USA
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
98GF Score

Get the complete analysis for STU:LHU

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.00
Price
€81.33
GF Value